(XD9U) Xtrackers MSCI USA 1C - Ratings and Ratios
US, stocks, large-cap, mid-cap, equity
Description: XD9U Xtrackers MSCI USA 1C
The Xtrackers MSCI USA UCITS ETF aims to replicate the performance of the MSCI Total Return Net USA Index, which which tracks the performance of large and medium-sized sized companies in the United States. The fund achieves this by holding a diversified portfolio of shares in the same proportion as theIndex, thereby providing broad exposure to the US equity market.
By design, the fund reinvests dividends and distributions after tax, making it an attractive option for investors seeking long-term growth. With an Assets Under Management (AUM of approximately 4.99 billion EUR, the fund demonstrates a significant presence in the ETF market. As a US Large-Cap Blend Equity ETF, it offers is well-positioned to capture the performance of the US stock market, which is dominated by large-cap stocks.
Based on the available technical data, the with a current price of 154.03 and a 200-day moving average of 156.03, the ETF is slightly below its long-term trend. The Average True Range (ATR) of 2.17, or 1.41%, suggests moderate volatility. Given the current price action and the fact that the ETF is near the lower end of its 52-week range (131.40 - 172.7), a potential bounce or consolidation could be anticipated. However, a break below the 52-week low could signal further downside.
From a fundamental perspective, the is a well-established player in the US equity ETF space. With aAUM of 4.994M EUR, it enjoys economies of scale and and a diversified investor base. The The funds underlying index, the MSCI USA TR, has historically delivered robust returns, driven by the long-term growth of the US economy. As the US economy continues to evolve, the fund is well-positioned to capture the performance performance of the US stock market.
Looking ahead, if the US economy maintains its growth trajectory, the the fund is likely to to benefit from the overall market uptrend. However, any significant economic downturn could negatively impact the funds performance. Given the current technical and fundamental landscape, a reasonable forecast would be that the fund will continue to to trade within a moderate range, with potential for growth if the US market maintains its upward momentum.
Additional Sources for XD9U ETF
XD9U ETF Overview
| Market Cap in USD | 5,893m |
| Category | US Large-Cap Blend Equity |
| TER | 0.07% |
| IPO / Inception | 2014-05-09 |
XD9U ETF Ratings
| Growth Rating | 67.1 |
| Fundamental | - |
| Dividend Rating | 0.11 |
| Rel. Strength | -7.61 |
| Analysts | - |
| Fair Price Momentum | 150.27 EUR |
| Fair Price DCF | - |
XD9U Dividends
Currently no dividends paidXD9U Growth Ratios
| Growth Correlation 3m | 77.3% |
| Growth Correlation 12m | 20.3% |
| Growth Correlation 5y | 90.2% |
| CAGR 5y | 14.62% |
| CAGR/Max DD 5y | 0.62 |
| Sharpe Ratio 12m | 0.54 |
| Alpha | -7.36 |
| Beta | 0.811 |
| Volatility | 9.98% |
| Current Volume | 4.6k |
| Average Volume 20d | 7.6k |
As of July 04, 2025, the stock is trading at EUR 156.62 with a total of 4,627 shares traded.
Over the past week, the price has changed by +1.96%, over one month by +1.93%, over three months by +9.12% and over the past year by +6.08%.
Yes. Based on ValueRay's Analyses, Xtrackers MSCI USA 1C (XETRA:XD9U) is currently (July 2025) a good stock to buy. It has a ValueRay Growth Rating of 67.12 and therefor a clear technical positive rating according to historical growth.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of XD9U is around 150.27 EUR . This means that XD9U is currently overvalued and has a potential downside of -4.05%.
Xtrackers MSCI USA 1C has no consensus analysts rating.
According to our own proprietary Forecast Model, XD9U Xtrackers MSCI USA 1C will be worth about 173.7 in July 2026. The stock is currently trading at 156.62. This means that the stock has a potential upside of +10.92%.
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | - | - |
| Analysts Target Price | - | - |
| ValueRay Target Price | 173.7 | 10.9% |